Voyager Acquisition Corp.

Voyager Acquisition Corp.

VACH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$36.96M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Voyager Acquisition Corp.Voyager Acquisition Corp.0--44%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$36.96 Million
Enterprise Value$36.92 Million
Earnings per Share$0.36
Beta-0.37
Outstanding Shares19,976,345

Return

Return on Equity-43.92%ROE
Return on Assets2.47%
Return on Invested Capital137.62%

Valuation & Multiples

P/E Ratio-P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio-1.85Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-11.16
Enterprise Value to Net Income5
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %70.23%▼ 27.63%
Total Invested$159.25M▼ 39.65%
Investors Holding28▼ 15.00%

About Voyager Acquisition Corp.

8 employees
CEO: Christoph Antz

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a ...